166 related articles for article (PubMed ID: 38230512)
1. Progress in developing microphysiological systems for biological product assessment.
Mansouri M; Lam J; Sung KE
Lab Chip; 2024 Feb; 24(5):1293-1306. PubMed ID: 38230512
[TBL] [Abstract][Full Text] [Related]
2. The Current Status and Use of Microphysiological Systems by the Pharmaceutical Industry: The International Consortium for Innovation and Quality Microphysiological Systems Affiliate Survey and Commentary.
Baker TK; Van Vleet TR; Mahalingaiah PK; Grandhi TSP; Evers R; Ekert J; Gosset JR; Chacko SA; Kopec AK
Drug Metab Dispos; 2024 Feb; 52(3):198-209. PubMed ID: 38123948
[TBL] [Abstract][Full Text] [Related]
3. Microphysiological systems for human aging research.
Park S; Laskow TC; Chen J; Guha P; Dawn B; Kim DH
Aging Cell; 2024 Mar; 23(3):e14070. PubMed ID: 38180277
[TBL] [Abstract][Full Text] [Related]
4. Applications of microphysiological systems to disease models in the biopharmaceutical industry: Opportunities and challenges.
Irrechukwu O; Yeager R; David R; Ekert J; Saravanakumar A; Choi CK
ALTEX; 2023; 40(3):485-518. PubMed ID: 36648096
[TBL] [Abstract][Full Text] [Related]
5. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology.
Watson DE; Hunziker R; Wikswo JP
Exp Biol Med (Maywood); 2017 Oct; 242(16):1559-1572. PubMed ID: 29065799
[TBL] [Abstract][Full Text] [Related]
6. Pumped and pumpless microphysiological systems to study (nano)therapeutics.
Lee EJ; Krassin ZL; Abaci HE; Mahler GJ; Esch MB
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1911. PubMed ID: 37464464
[TBL] [Abstract][Full Text] [Related]
7. Microphysiological systems in early stage drug development: Perspectives on current applications and future impact.
Kopec AK; Yokokawa R; Khan N; Horii I; Finley JE; Bono CP; Donovan C; Roy J; Harney J; Burdick AD; Jessen B; Lu S; Collinge M; Sadeghian RB; Derzi M; Tomlinson L; Burkhardt JE
J Toxicol Sci; 2021; 46(3):99-114. PubMed ID: 33642521
[TBL] [Abstract][Full Text] [Related]
8. Introduction to a manuscript series on the characterization and use of microphysiological systems (MPS) in pharmaceutical safety and ADME applications.
Fabre K; Berridge B; Proctor WR; Ralston S; Will Y; Baran SW; Yoder G; Van Vleet TR
Lab Chip; 2020 Mar; 20(6):1049-1057. PubMed ID: 32073020
[TBL] [Abstract][Full Text] [Related]
9. [Development of Microphysiological Systems (MPSs) Based on Microfluidic Technology for Drug Discovery in Japan].
Kimura H
Yakugaku Zasshi; 2023; 143(1):39-44. PubMed ID: 36596538
[TBL] [Abstract][Full Text] [Related]
10. [Toward Regulatory Acceptance of MPS-Cardiac Safety Assessment as an Example].
Yamazaki D
Yakugaku Zasshi; 2023; 143(1):55-63. PubMed ID: 36596540
[TBL] [Abstract][Full Text] [Related]
11. Application of Microphysiological Systems to Enhance Safety Assessment in Drug Discovery.
Ewart L; Dehne EM; Fabre K; Gibbs S; Hickman J; Hornberg E; Ingelman-Sundberg M; Jang KJ; Jones DR; Lauschke VM; Marx U; Mettetal JT; Pointon A; Williams D; Zimmermann WH; Newham P
Annu Rev Pharmacol Toxicol; 2018 Jan; 58():65-82. PubMed ID: 29029591
[TBL] [Abstract][Full Text] [Related]
12. Combining a microphysiological system of three organ equivalents and transcriptomics to assess toxicological endpoints for cosmetic ingredients.
Indolfo NC; Ganzerla MD; Doratioto TR; Avelino TM; Tofani LB; Peroni LA; Rabelo RS; Arroteia KF; Figueira ACM
Lab Chip; 2023 Dec; 23(24):5092-5106. PubMed ID: 37921576
[TBL] [Abstract][Full Text] [Related]
13. Application of microphysiological systems for nonclinical evaluation of cell therapies.
Candarlioglu P; Delsing L; Gauthier L; Lewis L; Papadopoulos G; Freag M; Chan TS; Homan K; Fellows MD; Pointon A; Kojala K
ALTEX; 2024 May; ():. PubMed ID: 38746991
[TBL] [Abstract][Full Text] [Related]
14. Organs-on-a-Chip.
Low LA; Sutherland M; Lumelsky N; Selimovic S; Lundberg MS; Tagle DA
Adv Exp Med Biol; 2020; 1230():27-42. PubMed ID: 32285363
[TBL] [Abstract][Full Text] [Related]
15. The use of microphysiological systems to model metastatic cancer.
Jackson CE; Green NH; English WR; Claeyssens F
Biofabrication; 2024 Apr; 16(3):. PubMed ID: 38579739
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal microphysiological systems.
Blutt SE; Broughman JR; Zou W; Zeng XL; Karandikar UC; In J; Zachos NC; Kovbasnjuk O; Donowitz M; Estes MK
Exp Biol Med (Maywood); 2017 Oct; 242(16):1633-1642. PubMed ID: 28534432
[TBL] [Abstract][Full Text] [Related]
17. Organoids and Microphysiological Systems: New Tools for Ophthalmic Drug Discovery.
Bai J; Wang C
Front Pharmacol; 2020; 11():407. PubMed ID: 32317971
[TBL] [Abstract][Full Text] [Related]
18. Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation.
Rubiano A; Indapurkar A; Yokosawa R; Miedzik A; Rosenzweig B; Arefin A; Moulin CM; Dame K; Hartman N; Volpe DA; Matta MK; Hughes DJ; Strauss DG; Kostrzewski T; Ribeiro AJS
Clin Transl Sci; 2021 May; 14(3):1049-1061. PubMed ID: 33382907
[TBL] [Abstract][Full Text] [Related]
19. [Pharma challenges to adoption of microphysiological system in drug research and development, especially safety assessment].
Naraoka H
Nihon Yakurigaku Zasshi; 2023; 158(2):187-192. PubMed ID: 36858504
[TBL] [Abstract][Full Text] [Related]
20. Application of microphysiological systems in biopharmaceutical research and development.
Peterson NC; Mahalingaiah PK; Fullerton A; Di Piazza M
Lab Chip; 2020 Feb; 20(4):697-708. PubMed ID: 31967156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
